122
Participants
Start Date
November 20, 2020
Primary Completion Date
May 29, 2021
Study Completion Date
May 29, 2021
Echinaforce Chewable tablets
"Preventive treatment: 3X2 EC tablets daily during 2 + 2 months of prevention after run-in of 1 week and intermittent treatment break of 1 week without treatment + 1 month of voluntary follow-up prevention.~Acute treatment: 5 X 2 EC tablets daily for max. 10 days per individual vRTI or until symptom resolution."
Diagnostics and Consultation Center Convex EOOD, Sofia
Collaborators (2)
CONVEX CRO
UNKNOWN
d.s.h. statistical services GmbH
UNKNOWN
MediStat Ltd.
UNKNOWN
Biodome Clinical
UNKNOWN
Bodimed
UNKNOWN
PPES lab epigenetic signaling
UNKNOWN
A. Vogel AG
INDUSTRY